Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia

This publication has 26 references indexed in Scilit:

• Receptor negative homozygous FH and drug therapy
  Atherosclerosis, 1993
• Characterization of deletions in the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• THE LDL RECEPTOR LOCUS IN FAMILIAL HYPERCHOLESTEROLEMIA: Mutational Analysis of a Membrane Protein
  Annual Review of Genetics, 1990
• Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover
  The Journal of Pediatrics, 1988
• Immunoprecipitation of the low-density-lipoprotein (LDL) receptor and its precursor from human monocyte-derived macrophages
  Biochemical Journal, 1986
• HEART-LIVER TRANSPLANTATION IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLAEMIA
  Published by Elsevier ,1984
• The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia
  Atherosclerosis, 1977
• Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
  Cell, 1976
• Lipoprotein-Polyanion-Metal Interactions1 1This investigation was supported in part by U. S. Public Health Service Research Grant HE-02965, and Training Grant TI HE-5273 and PO-AM 13430.
  Published by Elsevier ,1973
• Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia
  JAMA, 1972